461
P. Kaukinen: Activities related to the present article: grant from Finland State Research Funding. Activities 462
not related to the present article: payment for lectures including service on speakers bureaus from MEDA 463
Oy, Pfizer Oy. Other relationships: disclosed no relevant relationships.
464 465
J. Podlipská: Activities related to the work under consideration for publication: disclosed no relevant 466
relationships. Relevant financial activities outside the submitted work: disclosed no relevant relationships.
467
Other relationships: disclosed no relevant relationships.
468 469
A. Guermazi: Activities related to the work under consideration for publication: disclosed no relevant 470
relationships. Relevant financial activities outside the submitted work: payment for consultancy from 471
MerckSerono, Genzyme, GE Healthcare, OrthoTrophix, TissueGene, AstraZeneca, Pfizer, stock/ stock 472
options from Boston Imaging Core Lab, LLC. Other relationships: disclosed no relevant relationships.
473 474
J. Niinimäki: Activities related to the work under consideration for publication: disclosed no relevant 475
relationships. Relevant financial activities outside the submitted work: disclosed no relevant relationships.
476
Other relationships: disclosed no relevant relationships.
477 478
P. Lehenkari: Activities related to the work under consideration for publication: disclosed no relevant 479
relationships. Relevant financial activities outside the submitted work: disclosed no relevant relationships.
480
Other relationships: disclosed no relevant relationships.
481 482
F. W. Roemer: Activities related to the work under consideration for publication: disclosed no relevant 483
relationships. Relevant financial activities outside the submitted work: stock/ stock options from Boston 484
Imaging Core Lab. (BICL), LLC. Other relationships: disclosed no relevant relationships.
485 486
M. T. Nieminen: Activities related to the work under consideration for publication: disclosed no relevant 487
relationships. Relevant financial activities outside the submitted work: disclosed no relevant relationships.
488
Other relationships: disclosed no relevant relationships.
489 490
J. M. Koski: Activities related to the work under consideration for publication: disclosed no relevant 491
relationships. Relevant financial activities outside the submitted work: disclosed no relevant relationships.
492
Other relationships: disclosed no relevant relationships.
493 494
M AN US CR IP T
AC CE PT ED
S. Saarakkala: Activities related to the work under consideration for publication: Research Fellow Grant 495
from Academy of Finland. Relevant financial activities outside the submitted work: disclosed no relevant 496
relationships. Other relationships: disclosed no relevant relationships.
497 498
J. P. A. Arokoski: Activities related to the work under consideration for publication: disclosed no relevant 499
relationships. Relevant financial activities outside the submitted work: payment for lectures including service 500
on speakers bureaus from MSD Finland Oy, Pfizer Oy, Orion Oy. Other relationships: disclosed no relevant 501
relationships.
502 503 504
M AN US CR IP T
quadriceps femoris muscle in men with knee osteoarthritis. Arch Phys Med Rehabil 2008;89:2185-94.
509
3. Kim IJ, Kim HA, Seo YI, Jung YO, Song YW, Jeong JY, et al. Prevalence of knee pain and its influence 510
on quality of life and physical function in the Korean elderly population: a community based cross-sectional 511
study. J Korean Med Sci 2011;26:1140-6.
512
4. Davison MJ, Ioannidis G, Maly MR, Adachi JD, Beattie KA. Intermittent and constant pain and physical 513
function or performance in men and women with knee osteoarthritis: data from the Osteoarthritis Initiative.
514
Clin Rheumatol 2016;35:371-9.
515
5. Neogi T. The epidemiology and impact of pain in osteoarthritis. Osteoarthritis Cartilage 2013;21:1145-53.
516
6. Wenham CY, Conaghan PG. Imaging the painful osteoarthritic knee joint: what have we learned? Nat Clin 517
Pract Rheumatol 2009;5:149-58.
518
7. Hunter DJ, Guermazi A, Lo GH, Grainger AJ, Conaghan PG, Boudreau RM, et al. Evolution of semi-519
quantitative whole joint assessment of knee OA: MOAKS (MRI Osteoarthritis Knee Score). Osteoarthritis 520
Cartilage 2011;19:990-1002.
521
8. Sowers M, Karvonen-Gutierrez CA, Jacobson JA, Jiang Y, Yosef M. Associations of anatomical measures 522
from MRI with radiographically defined knee osteoarthritis score, pain, and physical functioning. J Bone 523
Joint Surg Am 2011;93:241-51.
524
9. Kim IJ, Kim DH, Jung JY, Song YW, Guermazi A, Crema MD, et al. Association between bone marrow 525
lesions detected by magnetic resonance imaging and knee pain in community residents in Korea.
526
Osteoarthritis Cartilage 2013;21:1207-13.
527
10. Kaukinen P, Podlipská J, Guermazi A, Niinimäki J, Lehenkari P, Roemer FW et al. Associations between 528
MRI-defined structural pathology and generalized and localized knee pain – The Oulu Knee Osteoarthritis 529
Study. Osteoarthritis Cartilage 2016 doi: 10.1016/j.joca.2016.05.001.
530
11. Link TM, Steinbach LS, Ghosh S, Ries M, Lu Y, Lane N, et al. Osteoarthritis: MR imaging findings in 531
different stages of disease and correlation with clinical findings. Radiology. 2003;226:373-81.
532
12. Wluka AE, Wolfe R, Stuckey S, Cicuttini FM. How does tibial cartilage volume relate to symptoms in 533
subjects with knee osteoarthritis? Ann Rheum Dis 2004;63 264-8.
534
13. Lange AK, Fiatarone Singh MA, Smith RM, Foroughi N, Baker MK, Shnier R, et al. Degenerative 535
meniscus tears and mobility impairment in women with knee osteoarthritis. Osteoarthritis Cartilage 536
osteoarthritis. Knee Surg Sports Traumatol Arthrosc 2014;22:2013-25.
540
M AN US CR IP T
AC CE PT ED
15. Creamer P, Lethbridge-Cejku M, Hochberg MC. Factors associated with functional impairment in 541
symptomatic knee osteoarthritis. Rheumatology (Oxford) 2000;39:490-6.
542
16. Davis MA, Ettinger WH, Neuhaus JM, Mallon KP. Knee osteoarthritis and physical functioning:
543
evidence from the NHANES I Epidemiologic Followup Study. J Rheumatol. 1991;18:591-8.
544
17. Perrot S, Poiraudeau S, Kabir-Ahmadi M, Rannou F. Correlates of pain intensity in men and women with 545
Radiographs of Arthritis. F. A. Davis; 1963.
549
19. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of womac: a health 550
status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy 551
in patients with osteoarthritis of the hip or knee. J Rheumatol 1988;15:1833-40.
552
20. Thompson LR, Boudreau R, Hannon MJ, Newman AB, Chu CR, Jansen M, et al. The knee pain map:
553
reliability of a method to identify knee pain location and pattern. Arthritis Rheum 2009;61:725-31.
554
21. Dobson F, Hinman RS, Roos EM, Abbott JH, Stratford P, Davis AM, et al. OARSI recommended 555
performance-based tests to assess physical function in people diagnosed with hip or knee osteoarthritis.
556
Osteoarthritis Cartilage 2013;21:1042-52.
557
22. Reuben DB, Siu AL. An objective measure of physical function of elderly outpatients. The Physical 558
Performance Test. J Am Geriatr Soc 1990;38:1105-12.
559
performance measures: a longitudinal study evaluating outcome following total hip and knee arthroplasty.
564
BMC Musculoskelet Disord. 2005;6:3.
565
25. Kennedy DM, Stratford PW, Hanna SE, Wessel J, Gollish JD. Modeling early recovery of physical 566
function following hip and knee arthroplasty. BMC Musculoskelet Disord 2006; 7: 100.
567
26. Gill S, McBurney H. Reliability of performance-based measures in people awaiting joint replacement 568
surgery of the hip or knee. Physiother Res Int 2008;13:141-52.
569
27. Roemer FW, Kwoh CK, Hannon MJ, Hunter DJ, Eckstein F, Wang Z et al. Can structural joint damage 570
measured with MR imaging be used to predict knee replacement in the following year? Radiology 571
2015;274:810-20 572
28. Cohen, J. Statistical power analysis for the behavioral sciences, Second Edition. Hillsdale, NJ: Lawrence 573
Erlbaum Associates 1988.
574
M AN US CR IP T
AC CE PT ED
29. Edwards MH, van der Pas S, Denkinger MD, Parsons C, Jameson KA, Schaap L et al. Relationships 575
between physical performance and knee and hip osteoarthritis: findings from the European Project on 576
Osteoarthritis (EPOSA). Age Ageing 2014;43:806–813.
577
30. Zambon S, Siviero P, Denkinger M, Limongi F, Castell MV, van der Pas S et al. Osteoarthritis, 578
Comorbidity And Pain: Their role in Determining Functional Limitations in older populations (European 579
Project on osteoarthritis). Arthritis Care Res (Hoboken) 2015:22755.
580
31. Claire YJ Wenham and Philip G Conaghan. Imaging the painful osteoarthritic knee joint: what have we 581
learned? Nature Clin Pract Rheum 2009;3:149-158.
582
32. Hunter DJ, Zhang W, Conaghan PG, Hirko K Menashe L, Li L et al. Systematic review of the 583
concurrent and predictive validity of MRI biomarkers in OA. Osteoarthritis Cartilage 2011; 19:557-588.
584
33. Guermazi A, Niu J, Hayashi D, Roemer FW, Englund M, Neogi T, et al. Prevalence of abnormalities in 585
knees detected by MRI in adults without knee osteoarthritis: population based observational study 586
(Framingham Osteoarthritis Study). BMJ 2012;345:e5339.
587
34. Wise BL, Niu J, Felson DT, Hietpas J, Sadosky A, Torner J et al. Functional Impairment Is a Risk Factor 588
for Knee Replacement in the Multicenter Osteoarthritis Study. Clin Orthop Relat Res 2015;473:2505–2513.
589
35. Lee J, Chang RW, Ehrlich-Jones L, Kwoh CK, Nevitt M, Semanik PA et al. Sedentary behavior and 590
physical function: objective evidence from the Osteoarthritis Initiative. Arthritis Care Res (Hoboken).
591
2015;67:366-73.
592
36. Neuman P, Owman H, Müller G, Englund M, Tiderius CJ, Dahlberg LE. Knee cartilage assessment with 593
MRI (dGEMRIC) and subjective knee function in ACL injured copers: a cohort study with a 20 year follow-594
up. Osteoarthritis Cartilage 2014;22:84-90.
595
37. Phan CM, Phan TM, Link G, Blumenkrantz TC, Dunn MD, Ries LS et al. MR imaging findings in the 596
follow-up of patients with different stages of knee osteoarthritis and the correlation with clinical symptoms.
597
Eur Radiol 2006;16:608–618.
598
38. Kornaat PR, Kloppenburg M, Sharma R, Botha-Scheepers SA, Le Graverand MP, Coene LN et al. Bone 599
marrow edema-like lesions change in volume in the majority of patients with osteoarthritis; associations with 600
clinical features. Eur Radiol. 2007;12:3073-8.
601
39. Wildi LM, Raynauld JP, Martel-Pelletier J, Abram F, Dorais M, Pelletier JP. Relationship between bone 602
marrow lesions, cartilage loss and pain in knee osteoarthritis: results from a randomised controlled clinical 603
trial using MRI. Ann Rheum Dis 2010;69:2118-24.
604
40. Wesseling J, Bierma-Zeinstra SM, Kloppenburg M, Meijer R, Bijlsma JW. Worsening of pain and 605
function over 5 years in individuals with ‘early’ OA is related to structural damage: data from the 606
Osteoarthritis Initiative and CHECK (Cohort Hip & Cohort Knee) study. Ann Rheum Dis 2015;74:347–353.
607
41. Wenger A, Englund M, Wirth W, Hudelmaier M, Kwoh K, Eckstein F. Relationship of 3D meniscal 608
morphology and positionwith knee pain in subjects with knee osteoarthritis: a pilotstudy. Eur Radiol 609
2012;22:211–220.36.
610
M AN US CR IP T
AC CE PT ED
42. Van Ginckel A, Bennell KL, Campbell PK, Wrigley TV, Hunter DJ, Hinman RS. Location of knee pain 611
in medial knee osteoarthritis: patterns and associations with self-reported clinical symptoms. Osteoarthritis 612
Cartilage 2016;24:1135-42 613
43. Mizner RL, Petterson SC, Clements KE, Zeni JA,Jr, Irrgang JJ, Snyder-Mackler L. Measuring functional 614
improvement after total knee arthroplasty requires both performance-based and patient-report assessments: a 615
longitudinal analysis of outcomes. J Arthroplasty 2011;265:728-737.
616
44. Stratford PW, Kennedy DM, Riddle DL. New study design evaluated the validity of measures to assess 617
change after hip or knee arthroplasty. J Clin Epidemiol 2009;623:347-352.
618
45. Stratford PW, Kennedy DM, Woodhouse LJ. Performance measures provide assessments of pain and 619
function in people with advanced osteoarthritis of the hip or knee. Phys Ther 2006;8611:1489-96; discussion 620
1496-1500.
621
46. de Rooij M, van der Leeden M, Heymans MW, Holla JF, Häkkinen A, Lems WF et al. Prognosis of Pain 622
and Physical Functioning in Patients With Knee Osteoarthritis: A Systematic Review and Meta-623
Analysis.Arthritis Care Res (Hoboken). 2016;68:481-92.
624
47. Scopaz KA, Piva SR, Wisniewski S, Fitzgerald GK. Relationships of fear, anxiety, and depression with 625
physical function in patients with knee osteoarthritis. Arch Phys Med Rehabil. 2009;90:1866-73.
626
48. Helminen EE, Sinikallio SH, Valjakka AL, Väisänen-Rouvali RH, Arokoski JP. Determinants of pain 627
and functioning in knee osteoarthritis: a one-year prospective study. Clin Rehabil. 2016;30:890-900.
628 629 630
M AN US CR IP T
AC CE PT ED
FIGURE LEGENDS